Biotherapeutic Department Of Chinsese PLA Gereral Hospital

Quiénes somos

  • enero 1, 1970
    GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.